scispace - formally typeset
R

Rüdiger Klein

Researcher at Max Planck Society

Publications -  191
Citations -  38264

Rüdiger Klein is an academic researcher from Max Planck Society. The author has contributed to research in topics: Erythropoietin-producing hepatocellular (Eph) receptor & Ephrin. The author has an hindex of 89, co-authored 185 publications receiving 36387 citations. Previous affiliations of Rüdiger Klein include Princeton University & Harvard University.

Papers
More filters
Journal ArticleDOI

Role of Brain Insulin Receptor in Control of Body Weight and Reproduction

TL;DR: Mice created with a neuron-specific disruption of the IR gene showed increased food intake, and both male and female mice developed diet-sensitive obesity with increases in body fat and plasma leptin levels, mild insulin resistance, elevated plasma insulin levels, and hypertriglyceridemia.
Journal ArticleDOI

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

TL;DR: Conditional mutagenesis of Gr in the nervous system provides genetic evidence for the importance of Gr signalling in emotional behaviour because mutant animals show an impaired behavioural response to stress and display reduced anxiety.
Journal ArticleDOI

The trk proto-oncogene encodes a receptor for nerve growth factor.

TL;DR: The results indicate that gp140trk is a functional NGF receptor that mediates at least some of the signal transduction processes initiated by this neurotrophic factor.
Journal ArticleDOI

Mechanisms and functions of eph and ephrin signalling

TL;DR: The concept of bidirectional signalling has emerged as an important mechanism by which Ephs and ephrins control the output signal in processes of cell–cell communication.
Journal ArticleDOI

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor.

TL;DR: It is demonstrated that ErbB4 is an essential in vivo regulator of both cardiac muscle differentiation and axon guidance in the central nervous system (CNS) and differences in the hindbrain phenotypes of these mutants are consistent with the action of a new Erb B4 ligand in the CNS.